Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CCCC
EMBC
Add up to 3 more stocks
CCCC
C4 Therapeutics, Inc.
-5.18%
$2.83-0.16Delayed quote: Oct 6, 2026, 3:20 PM EDT
Market Cap
$313.46M
52W Range
$1.69 - $5.17
EMBC
Embecta Corp.
+1.62%
$5.97+0.09Delayed quote: Oct 6, 2026, 3:20 PM EDT
Market Cap
$354.48M
52W Range
$2.77 - $14.91
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 4.04 |
| Forward P/E | N/A | 3.39 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.27 | N/A |
| P/S Ratio | 8.95 | 0.35 |
| P/FCF Ratio | N/A | 2.15 |
| EV/EBITDA | N/A | 5.38 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 77.8% | 59.9% |
| Operating Margin | -290.7% | 24.9% |
| Net Margin | -289.4% | 8.6% |
| ROE | -41.0% | N/A |
| ROA | -28.2% | 6.9% |
| ROIC | -35.9% | 18.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.45 | 1.68 |
| Quick Ratio | 5.45 | 1.68 |
| Debt/Equity | 0.23 | N/A |
| Interest Coverage | N/A | 3.07 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 5.4% |
| Payout Ratio | N/A | 21.6% |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.